It is appropriate to create new pharmaceutical products within developing countries

Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character
R G Buckles

Abstract

Arguments are presented for utilizing local product development as an appropriate way to solve many of the current medical problems of the Third World. Guidelines for selecting problems amenable to this approach are provided, and the risks attendant on such an activity outlined. It is suggested that organizations such as the World Health Organization can encourage this approach by helping to provide training in product development and by providing consulting services for organizations in the developing world.

Citations

May 4, 2005·Journal of Mathematical Biology·Thomas Nagylaki
Aug 11, 2005·Physical Review Letters·Paul M AlsingG J Milburn
Jun 25, 2005·Statistics in Medicine·M Dell'Omodarme, M C Prati
Dec 1, 1981·Royal Society of Health Journal·B Benjamin
Jun 2, 2004·The European Physical Journal. E, Soft Matter·F BenzouineM Himmi
Jan 22, 2011·The European Physical Journal. E, Soft Matter·M BenhamouF Elhajjaji
Aug 9, 2011·The European Physical Journal. E, Soft Matter·M Benhamou
Mar 23, 2007·The European Physical Journal. E, Soft Matter·M Mancini, C Oguey
Apr 12, 2006·Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics·P V LarsenS Trillo
May 22, 2018·Journal of Inequalities and Applications·Mohammad Masjed-JameiJuan J Nieto
Jul 27, 2002·Adverse Drug Reactions and Toxicological Reviews·Caroline J Hardwicke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.